Copy number aberrations are recognized to be important in cancer as they may localize to regions harboring oncogenes or tumor suppressors. Such genomic alterations mediate phenotypic changes through their impact on expression. Both cis-and transacting alterations are important since they may help to elucidate putative cancer genes. However, amidst numerous passenger genes, trans-effects are less well studied due to the computational difficulty in detecting weak and sparse signals in the data, and yet may influence multiple genes on a global scale. We propose an integrative approach to learn a sparse interaction network of DNA copynumber regions with their downstream transcriptional targets in breast cancer. With respect to goodness of fit on both simulated and real data, the performance of sparse network inference is no worse than other state-of-the-art models but with the advantage of simultaneous feature selection and efficiency. The DNA-RNA interaction network helps to distinguish copy-number driven expression alterations from those that are copy-number independent. Further, our approach yields a quantitative copy-number dependency score, which distinguishes cis-versus trans-effects. When applied to a breast cancer data set, numerous expression profiles were impacted by cis-acting copy-number alterations, including several known oncogenes such as GRB7, ERBB2, and LSM1. Several trans-acting alterations were also identified, impacting genes such as ADAM2 and BAGE, which warrant further investigation. Availability: An R package named lol is available from www.markowetzlab.org/software/lol.html.
INTRODUCTION
C OPY-NUMBER alterations, including both germline variants and somatic copy number aberrations are associated with disease [1] . Somatic aberrations are particularly important for tumorigenesis. For example, oncogene activation by gene amplification or gene deletion resulting in the loss of a tumor suppressor can cause transcriptional changes ( Fig. 1) , which contribute to cancer pathogenesis. Gene expression can be influenced by copy-number alterations in proximal genes within a several Mb window (cis-acting), as well as remote alterations throughout the genome (transacting), as depicted in Fig. 1 . One of the challenges in cancer genomics is to characterize such intermediate phenotypic changes caused by both cis-and trans-copy-number alterations. However, this task is complicated by the presence of numerous passenger genes amidst the limited set of drivers that contribute to tumor progression.
Detectingcis -and trans-regulatory effects. An integrative analysis of copy-number alterations and expression has the potential to uncover regulatory relationships between them (Fig. 1 ). The availability of genome-wide copy number and gene expression data facilitates the discovery of such regulatory maps, but few studies have quantitatively assayed the effect of both cis-and trans-copy number on the expression abundance in the same primary tumor samples. Given the inherent noise in such data and the scale of genomic information, the detection of both cis-and transacting effects between DNA and RNA on a genome-wide basis is a difficult task. In particular, the identification of driver alterations amidst numerous passenger events is particularly challenging and complicated by frequent cooccurring alterations. Thus, despite considerable efforts, relatively few drivers have been identified in any one cancer type, and many relevant copy-number alterations remain to be characterized.
Previous research. This area of research is of key importance since certain somatic alterations contribute to tumorigenesis, and their characterization is critical for the development of targeted therapeutic agents. Not surprisingly, the association between copy number and mRNA expression data has gained considerable attention. One of the first studies to combine gene expression and DNA copynumber data [1] concluded that 62 percent of highly amplified genes demonstrated moderate to high-expression levels. Others have similarly identified genes that exhibit gain/loss and simultaneous over-/underexpression in cancer [2] , [3] , but it has been noted that chromosomal amplifications do not necessarily result in the overexpression of the genes located in the same cytoband [4] .
In summary, recent studies have focused on the local effects of copy number on expression, and few have considered trans-acting effects on a global scale. Correlation analysis remains in widespread use for these types of comparisons due to its efficiency [5] , and has more recently been used to query trans-effects on a genome-wide level [6] . Several more sophisticated tools have also been proposed. For example, Menezes et al. [7] made use of gene sets instead of individual genes in regression models in their efforts to integrate the two data types. However, simple regression has limited power in face of the immense amount of genomic data. Moreover, their focus is on cisevents and does not account for remote interactions.
Our approach. In order to find copy-number driven expression alterations, we propose a new framework for reconstructing a genome-wide regulatory map by exploiting genomic and transcriptomic data. The objective of the proposed framework is to set up an interaction network between copy-number alterations and expression changes (arrows in Fig. 1 ). By interpreting global gene expression changes in the context of copy-number alterations, the network has the potential to uncover both cis-and transregulatory elements. Our approach combines several key ideas: First, we employ an L 1 -regularized regression model, which allows for simultaneous feature selection and model fitting and generalizes well in high dimensions. Second, we introduce a combination of global and local search strategies to optimally set the regularization parameter in our model. Third, we quantitatively measure each transcript's copy-number dependence.
In a simulation study we assess the accuracy of network reconstruction using our approach compared to several other network models. Using a published breast cancer data set [8] , where the "true" network is not known, we compare the model fit of our approach to other state-of-the-art predictors. Further, we demonstrate its advantages over correlation analysis, a commonly used approach in studies of this kind [1] , [6] , [8] . As a result, we are able to uncover key genes known in breast cancer biology as well as to discover novel genes driven in trans by copy-number effects.
METHOD
The framework for investigating trans-acting effects is based on linear regression with L 1 -regularization (Section 2.1). The strength of regularization is chosen adaptively for each gene by a combined global and local search over the space of regularization parameters (Section 2.2). The results are incorporated into a quantitative measure for copy-number dependence by comparing the variance of the model residuals with and without a locus of interest (Section 2.3).
L 1 -Constrained Regression Selects Most
Influential Genomic Loci for Each Transcript
We use L 1 -constrained regression (a.k.a the Lasso [9] ) to identify the effect of genome-wide copy-number alterations (the predictor variable), on gene expression profiles (the response variable). L 1 -regression minimizes the sum of squared errors between the response and predictors, while keeping a bound on the sum of the absolute values of the regression coefficients. By penalizing the absolute sum of coefficients, L 1 -constrained regression effectively shrinks nonsignificant coefficients to zero. In contrast, L 2 -constrained regression (a.k.a ridge regression) keeps a bound on the sum of the squared values of the regression coefficients and generally results in small, but nonzero, regression coefficients. Hence, L 1 -regression is a prominent method in high-dimensional studies as a result of its efficiency in performing sparse statistical inference on thousands of variables [9] . Efficient computational methods also exist to infer the entire path of variable inclusion over different choices of regularization strength [10] .
The model is framed as follows: We assume matched copy-number data of p DNA regions X ¼ ðx 1 ; x 2 ; . . . ; x p Þ and mRNA expression data of q genes Y ¼ ðy 1 ; y 2 ; . . . ; y q Þ, both available from n tumor samples. For gene i with expression profile y i , let X i be the candidate prediction model with regression coefficients i ¼ ð i1 ; i2 ; . . . ; in Þ. The Lasso model is then given bŷ
where kxk 2 ¼ P x 2 i indicates the L 2 norm measuring the distance between model prediction and the response, and kxk 1 ¼ P jx i j indicates the L 1 norm used to constrain the regression coefficients.
i in (1) is a regularization parameter controlling the sparsity and strength of regularization. By varying i ; L 1regression/Lasso adaptively includes predictors in the model (see Fig. 2 ). The subscript "i" emphasizes the fact that the optimization problem in (1) has to be solved for every gene. In particular, for each gene a regularization parameter i has to be chosen. In the next section, we utilize an efficient combination of global and local searches.
Adaptive Regularization by Combined Global and Local Search
The regularization parameter is crucial since it directly determines how many predictor vectors are to be included in the model. We perform a two-step procedure for selection of that combines a global search over a discrete set of candidate values with a local search around the optimal candidate. For the global search the likelihood function is evaluated by cross validation, whereas for the local search Brent's minimization without derivatives [11] is employed as implemented in the R package "penalized" Fig. 1 . Gene expression levels can be affected by both cis-and transacting copy-number alterations. Integrating gene expression and gene dosage information measured by microarrays can help to identify copynumber alterations that mediate transcriptional changes among many passenger events.
[12]. Brent's method combines the steps of golden section (a fast method based on binary divisions of the search space) with parabolic interpolation to efficiently zoom in onto the maximum.
.
Step 1 Global search: We perform 10-fold cross validation across a wide range of candidate values (gray lines in Fig. 3 ). Log-likelihood scores (black dots) are computed for each of these values to provide a point of focus for the next step. .
Step 2 Local search: At the point of the maximum log-likelihood of Step 1 (black line in Fig. 3 ), we perform a local search (gray box) with Brent's optimization to locate the optimal value of (dashed line). Having chosen an optimal value and computed the Lasso solution of (1) for each gene, we obtain a coefficient matrix B ¼ ð 1 ; 2 ; . . . ; n Þ. Because of the L 1 -constraint in the Lasso, this matrix will be sparsely populated and many coefficients will be zero. Matrix B represents the regulatory relationships between copy-number changes and transcriptional changes (illustrated by the arrows in Fig. 1) .
A technical note. Lasso assumes the predictor variables to be linearly independent. However, DNA copy-number data obtained from high-resolution microarrays can exhibit strong correlations between probes. Therefore, copy-number data should be first tested for independence and, if necessary, the dimensionality should be reduced with an appropriate method such as that implemented in the R package "CGHregions" [13] to yield regions with independent signatures. We implemented our framework in R using functions from the "penalized" and "CGHregions" packages.
A Quantitative Measure of Copy-Number Dependence
The proposed framework allows for the quantitative assessment of the dependency between gene expression and copy number, both in cis and in trans. The underlying assumption is that the predictive power of a model can be measured by the proportion of variance explained, i.e., the ratio of the variance of modeling residuals with or without the incorporation of one or more predictors. More formally, given two models-one with and one without a set of predictors-the negative natural logarithm of the ratio of the variance between the prediction residuals
can be used as a score indicating the dependency of the response variable on the predictor(s). Thus, if the variance of the residuals is reduced after incorporating copy-number predictors, the dependence of expression responses on copy number can be quantitatively measured. We assume that all responses and predictors are centered and standardized to unit variance, so that results across multiple regression models are comparable. We then further separate the copy-number predictors into two groups representing cis-and trans-effects, respectively. The relationship between expression and copy number can then be classified into three categories, cis-dependent, transdependent, and copy-number independent.
Formally, we delineate these relations based on the sparse coefficients given by (1) by comparing a sequence of nested models that successively incorporates additional predictors: no predictor, copy-number alterations in cis, and both cis-and trans-copy-number changes
Equations (3) (4) (5) show the difference between these models, while (2) allows for the effect of additional predictors to be estimated by measuring the difference in variance explained between any two equations in (3) (4) (5) .
Copy-number dependency score. Combining (2), (3), and (5) , the dependency between the expression of a gene i' and a particular copy-number alteration can be calculated Similarly, the dependency of an expression y i on a transeffects conditioned on the local cis-effects can be calculated based on (4) and (5)
Given these two scores, we can rank genes according to their copy-number dependence, and can distinguish between cis and transdependency. Note that by incorporating the cis-predictor x i in (4) and (5), we remove the cis-effect before exploring the trans-effect P j;j6 ¼i x j , which is equivalent to a conditional independence test.
EXPERIMENTS ON SIMULATED NETWORKS
Simulated data were generated to test the performance of the L 1 method on network structure inference. Let X $ Nð0; 1Þ be a matrix with p Gaussian variables each of n samples, and T be a sparse matrix of p by q generated from randomly sampling 50 nonzero coefficients from a distribution Nð0; 1Þ. From X and T , a response vector Y ¼ XT with q variables is generated. Both X and Y are added with centered Gaussian noise Nð0; 2 Þ. The objective is to infer T from X and Y .
Two popular network reconstruction methods in the literature that are applicable to the small n, large p problem are compared with the L 1 method, namely Gaussian Graphical Models [14] and Partial Least Squares [15] . However, to remove any ambiguity that could be caused by the different numbers of inferred relations, the number of relations, i.e., total number of nonzero coefficients in T are known to all methods.
The performance of the methods in comparison is judged by whether the nonzero coefficients in T can be correctly detected. Data are simulated with p, the number of variables in X, varying from 100 to 2,000 and sample size n varying from 50 to 500. The number q of variables in Y is equal to q. For each setting of p and n, data sets are generated with different noise levels 2 2 f0:05; 0:1; 0:2g. For the result, precision and recall statistics for the inference results of all variables in Y are computed and averaged across noise levels.
The precision and recall curves, grouped by values of p, are plotted in Fig. 4 . The advantage of the L 1 method can be clearly seen: in all scenarios precision and recall are higher than for the competitors. The difference is most pronounced for large values of p, which is especially important for real-world applications. In summary, the simulations show that the proposed method outperforms other state-of-the-art methods in terms of accuracy in reconstructing regulatory networks.
A GENOME-WIDE MAP OF c cis-AND t trans-REGULATION IN BREAST CANCER
To demonstrate the effectiveness of the proposed method in a real-world application, we used a breast cancer data set with 89 samples which were assayed at both genomic and transcriptional level using microarrays [8] . The gene expression data and the BAC array copy-number data were both log normalized (for details see [8] ) and subsequently standardized.
A Quantitative Assessment of Prediction Accuracy
While the simulations showed the accuracy of our framework in network reconstruction, this same approach cannot be repeated on real data where the true network is unknown. However, we can ask how well our model predicts gene expression from copy-number alterations compared to other state-of-the-art regression models. We compared L 1 -constrained regression with three other well-known prediction models: Random Forests [16] , SVM [17] , and Recursive Partitioning [18] . Each method uses copy-number data to predict expression profiles and accuracy is measured in terms of the mean squared error of the prediction. We employed the R implementation of these approaches for this comparison ("randomForest," "e1071," and "rpart"). Models were trained with a subset of samples in the Chin et al. data set [8] and the fitted models were used to predict the rest of samples. Specifically, 100 expression profiles were randomly selected and for each of the expression profile, models were fit with 7=8 ðn ¼ 78) of the samples. The mean squared errors were evaluated for prediction with the test set 1=8 ðn ¼ 11). The Random Forests method was trained with 500 trees so that the computational time is on the same scale as that of other methods. SVM was trained with a linear kernel.
The results in Fig. 5 show that, in terms of accuracy, the L 1 -constrained regression is not outperformed by any competitor. Additionally, it provides a sparser solution than the other models: On average L 1 -regression used less than seven features, while Recursive Partitioning used more than 32 and SVM and Random Forests used all of them. Thus, the L 1 -model combines sparsity with highprediction accuracy. This is important since the selected features directly point to the relevant copy-number alterations, which modulate expression. This experiment illustrates the utility of the proposed framework in integrating copy number and expression data to elucidate regulatory networks.
The Global Impact of Copy-Number Alterations on Gene Expression
The proposed framework was used to study the impact of copy-number alterations on gene expression profiles in the Chin et al. data set. The expression profiles were filtered to exclude nonvariable probes, which exhibited standard deviations <0:2 across samples. Using (6) we can rank expression probes based on their copy-number dependency score, with the top 20 copy-number dependent probes displayed in Table 1 (note DKFZP564 is short for DKFZP564L0862). For these 20 probes, we further decompose the effects from different explanatory predictors into three categories (Fig. 6) . The three categories are: transacting copy-number alterations, defined as effects associated with copy-number alterations >5 MB from the expression probe of interest, cis-acting copy-number alterations, defined as effects within a 5 MB cis-region, and other, which denotes expression profiles for which the variance is not explained by copy-number alterations. Notably, several known oncogenes are present such as ERBB2 and GRB7 on 17q21.31 and their neighbors MGC9753 and MLN64. ERBB2 is amplified in approximately 15 percent of breast cancer cases, and concomitant overexpression is typically observed. Hence, strong cis-effects are anticipated in this region. In line with this, Fig. 6 shows that a large proportion of the expression variation is explained by cisacting copy-number events. 6 . Decomposition of explanatory variables for the top 20 copynumber dependent expression reveals cis-driven genes LSM1, GRB7, and ERBB2, as well as trans-driven genes ADAM2 and BAGE. Here, the cis and trans-acting copy-number associations, and copy number independent effects (Other) are indicated relative to unit variance.
TABLE 1 Top 20 Expression Probes Ranked by the Copy-Number Dependency Score Includes Many Key Breast Cancer Genes
Another gene which localizes to the 8p12 amplicon, LSM1, has been reported as a breast cancer oncogene [19] and was found to be associated with lung cancer progression [20] . As noted in these studies, we also observe that this gene is strongly cis-associated.
Trans-effects have been less thoroughly reported. Here, we identify several notable genes influenced by transacting alterations, including BAGE and ADAM2. BAGE encodes a tumor antigen recognized by autologous cytolytic lymphocytes and was recently reported as a novel epigenetic biomarker in colon cancer. The authors found that that BAGE was hypermethylated in normal tissues and hypomethylated in 98 percent of human cancers [21] . More recently, BAGE has been noted to play a role in the development of ovarian cancer, suggesting it may be an early biomarker of disease [22] . ADAM2 is located on 8p11.22 where frequent rearrangements have been observed [23] . The ADAM gene family encodes for metallopeptidases, which function in cell migration, cell adhesion, signal transduction, cell-cell, and cell-matrix interactions. Given that BAGE is known to be epigenetically regulated in other cancers, the strong trans association of this gene in the breast cancer data set suggests that trans effects may be mediated indirectly through DNA methylation or histone modification.
Among the top genes with functional annotations in Table 1 , RAE1, CDK5R1, and PARD6B are influenced by both cis and trans copy-number effects as shown in Fig. 6 . This indicates that copy-number alterations in distal genes as well as at these loci contribute to expression variation. RAE1 has been implicated in the cell cycle and can be downregulated by retinoic acid, hence facilitating APC (Cdh1)-mediated Skp2 degradation leading to the cell cycle arrest [24] , [25] . CDK5R1 encodes p35, a neuron-specific activator of cyclin-dependent kinase 5 (CDK5) which has been implicated in various diseases [26] , [27] . Increased CDK5 kinase activity may lead to aberrantly phosphorylated forms of the microtubule-associated protein tau, MAPT, which contributes to Alzheimer's disease [28] . Notably, MAPT is also a highly CN-dependent gene according to our scoring function (rank 46). CDK5 is implicated in cell proliferation and apoptosis in both prostate and breast cancer [26] , [27] . PARD6B is a transcriptional target of SRC-3 the Steroid receptor coactivator-3 (SRC-3/AIB1), which is a coactivator for nuclear receptors and other transcription factors, and a known oncogene [29] . Other highly ranked genes including NAT1 (rank 26) the Nacetyltransferase 1 which has been associated with various forms of cancer [30] . The fact that many of the genes that are highly ranked according to their copy-number dependency score are implicated in breast cancer development suggests that our approach may facilitate the identification of putative oncogenes.
Individual Examples of Copy-Number Driven Expression
We also examined the impact of copy number on individual expression profiles. For the purpose of comparison, the correlation between gene expression and genome-wide copy number was computed, and following False Discovery Rate (FDR) correction under the Benjamini-Hochberg procedure [31] , the results are plotted in Fig. 7 . Fig. 7a reveals very high correlation between the expression of the oncogene MYC and copy-number alterations on 3q26.2 and 5q12-5q34. In fact, these regions exhibit nearly as high a correlation as does 8q24 (which denotes the location of MYC itself). Here, the red histogram indicates positive correlation, while the blue histogram indicates negative correlation. Fig. 7b illustrates that the dependence of MYC expression on copy number at 5q21-5q34, when conditioned on its own copy number (8q24), is much smaller than that of copy number at 8q24, while the dependence on 3q26 vanishes. This is due to the fact that cooccurring events have been removed by the conditional dependence assumption in Lasso. Moreover, the effects of copy number at 9q22.2 and 11p11.12 are completely removed when conditioning on copy number at 8q24 as shown in Fig. 7a . In contrast, an apparently strong negative regulatory effect persists at the 17q21.31 locus, which harbors both WNK4 and the breast cancer susceptibility gene BRCA1, suggesting interactions between these key genes and MYC.
A comparison between the correlation analysis and Lasso for the NCOA3 gene, a nuclear coactivator for the estrogen receptor, is also informative. The impact of Chromosome 17 (at 17q21.33) on the expression of NCOA3 is evident in the correlation analysis ( Fig. 8a) , but is not present in the Lasso analysis as shown in Fig. 8b . In contrast, copy number at 8q21.13 exhibits a much smaller negative correlation with NCOA3 expression than that from 17q21.33 and 8p21.1. While the effects from 17q21.33 and 8p21.1 are removed by Lasso, 8q21.13 persists as does 11q23.3 and 17q23.2, suggesting that they may cooperate with NCOA3. Several key genes reside within the 8q21.13 region, including TPD52 (tumor protein D52 isoform 1) and STMN2, a growth-associated protein. Similarly, 11q23.3 harbors numerous genes such as TRIM29 which contains multiple zinc finger motifs, and POU2F3 which encodes a transcription factor. Breast carcinoma amplified sequence 3 (BCAS3) localizes to 17q23.2 as does PPM1D, as protein phosphatase, and TBX4 which encodes a T-box transcription factor. The importance of elucidating the mechanisms underlying these interactions is highlighted by the fact that NCOA3 is overexpressed in 60 percent of primary human breast tumors, and elevated expression is associated with tamoxifen resistance and poor prognosis [32] .
DISCUSSION
This paper presents an efficient framework for integrating genome-wide copy number and expression data. Both cisand trans-regulatory effects can be quantitatively measured using conditional probabilities, and L 1 -constrained regression aids the selection of relevant predictor variables for inclusion in the model. In summary, our proposed framework allows for a genome-wide description of the effect of gene dosage on gene expression, and partitions copynumber dependent and independent transcriptional changes. This approach yields a global view of the DNA-RNA relations, and can prioritize downstream targets for subsequent functional validation. . For more information on this or any other computing topic, please visit our Digital Library at www.computer.org/publications/dlib.
